Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study suggests that hair follicles may be the primary target in the onset of various skin diseases, potentially spreading to affect the surrounding epidermis.

This study questions whether lymphocytic infiltrate and fibrosis observed after uncomplicated hair transplants might be expected without indicating lichen planopilaris.

This study concluded that hair loss is a common issue after vertical sleeve gastrectomy, influenced by serum leucine concentration, and is not typically due to low iron or zinc levels.

The examined study explored how trichoscopic evaluations of female pattern hair loss might relate to disease severity and histological changes, but the authors highlighted methodological issues such as unclear sample size determination and insufficient control of confounding variables, which limit the results' generalizability and reproducibility.

In this study of female pattern hair loss, oral finasteride 5 mg and topical minoxidil 5% both significantly improved hair density and patient satisfaction over 6 months, outperforming finasteride 2 mg, which showed limited improvement beyond the third month. All treatments were deemed safe.

This study reports that normal scalp and hair in Black Africans exhibited regular white dots and a preserved honeycomb pattern, with some showing peripilar casts and scales.

In this study, trichoscopy revealed hair shaft abnormalities similar to those seen in alopecia areata and chemotherapy-induced alopecia in patients over 12 months following hair restoration surgery.

This review summarizes existing literature on oral finasteride's pharmacology, efficacy, and side effects for treating female pattern hair loss, and explores alternative options like topical finasteride and dutasteride; it reports no new results.

This article discusses the participation of ISHRS members in the 2017 Practice Census survey and reports no new findings; it highlights involvement in the survey process.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

Finasteride can help with hair loss but may cause mental health issues like depression and anxiety.

This study reports that men with androgenic alopecia experience altered neuroactive steroid levels associated with persistent depression symptoms even after stopping finasteride treatment.

This study found that finasteride at 1 mg/day was the most effective dose for treating male pattern hair loss, with similar efficacy to 5 mg/day and better results than lower doses.

This study found that finasteride decreases DHT/T levels more significantly in the vertex scalp hair than in the occipital hair of patients with male pattern baldness.

In this study, treatment with finasteride 1 mg/day for five years significantly reduced the likelihood of further visible hair loss in men with androgenetic alopecia compared to placebo.

This study reported that combined oral finasteride and topical 5% minoxidil treatment in men with male-pattern hair loss improved hair growth by initiating anagen in pre-existing but deficient follicles, yet the growth rates remained unchanged and did not normalize hair productivity.

This case report describes a patient with frontal fibrosing alopecia experiencing significant hair regrowth and reversal of cutaneous atrophy after treatment with the 5α-reductase inhibitor finasteride.

This study found that finasteride 1 mg per day improved hair growth and slowed hair loss in Japanese men with male pattern hair loss compared to lower doses and placebo.

This article provides a case study on determining Regal Hair Salons Inc.'s federal income tax liability and financial reporting consistency with GAAP concerning gift card sales, with no specific new results reported.

This study suggests that type I 5-alpha reductase may also play a role in hair growth, with dutasteride potentially being more potent than finasteride in modulating key hair growth gene expressions.

This study reviewed trichoscopic images to assess hair loss, finding that ayurvedic signs (lakshanas) aligned with modern trichoscopic parameters, potentially aiding accurate diagnosis and management of hair conditions.

In this study, researchers investigated the alignment of trichoscopic findings with ayurvedic signs (lakshanas) for diagnosing hair loss, suggesting that integrating these perspectives could enhance diagnostics and management of hair and scalp conditions.

This study concluded that Sassle's almond-based hair serum is financially viable, with positive financial metrics across different sales scenarios, indicating potential for significant returns and strategic investment opportunities.

This study found that finasteride and luteolin may prevent hair loss and promote hair growth in vitro and in vivo by modulating specific gene expressions related to cell differentiation and apoptosis.

This study found that 94% of healthy men reported low libido and 92% reported erectile dysfunction as persistent sexual side effects after using finasteride for male pattern hair loss, with these effects lasting on average 40 months post-discontinuation.

This study found that 5 mg/day oral finasteride was effective and safe for improving hair outcomes in normoandrogenic postmenopausal women with androgenetic alopecia over 18 months.

This study reports that finasteride increases hair count by reactivating resting follicles in men with frontal male pattern hair loss, with continuous clinical improvement due to thickening and elongation of hair even after hair count stabilization.

This review examines reports of prolonged sexual dysfunction and depression associated with finasteride for male pattern hair loss, concluding that significant biases exist and further rigorous trials are needed to assess risks.

This study reported that prompt hair removal effectively treated hair tourniquet syndrome in infants, with all patients healing without complications.